help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Imperato-McGinley, J.
Right arrow Articles by Vaughan, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imperato-McGinley, J.
Right arrow Articles by Vaughan, E. D.

Endocrinology, Vol 131, 1149-1156, Copyright © 1992 by Endocrine Society


ARTICLES

Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies

J Imperato-McGinley, RS Sanchez, JR Spencer, B Yee and ED Vaughan
Department of Medicine, Cornell University Medical College, New York, New York 10021.

Studies were performed to compare the effects of 5 alpha-reductase inhibition and antiandrogen receptor blockade on differentiation of male internal and external genital structures and prostate in the rat. Dose-response studies were performed on male rats treated in utero during the period of sexual differentiation with either the potent 5 alpha-reductase inhibitor finasteride or the antiandrogen flutamide. The treated animals were raised to adulthood and killed, and genital structures were evaluated. Treatment with the 5 alpha-reductase inhibitor finasteride at a dose of 25 mg/kg.day resulted in significant feminization of the external genitalia. There was no further feminization of the genitalia at doses up to 300 mg/kg.day. Wolffian ductal differentiation occurred at all doses evaluated. Seminal vesicle weight, however, significantly decreased at 25 mg/kg.day, but without a further decrease at higher doses of the 5 alpha-reductase inhibitor. Vas deferens and epididymal weights were unchanged at all doses evaluated. There was a significant decrease in prostate size at 25 and 50 mg/kg.day, with no further decrease at higher doses. In flutamide- treated animals, complete feminization of the genitalia occurred at 24 mg/kg.day in all animals. At 18 mg/kg.day, Wolffian ductal differentiation occurred, but seminal vesicle weight was decreased. At dosages of 100, 200, and 300 mg/kg.day flutamide, the vas deferens was absent unilaterally or bilaterally, with small remnants of epididymal head and tail present. At dosages of 24 mg/kg.day and above, the prostate was absent. Studies with the 5 alpha-reductase inhibitor finasteride demonstrate the dependency of prostate and male external genital differentiation on dihydrotestosterone (DHT). However, unlike androgen receptor blockade with flutamide, finasteride did not totally abolish prostate differentiation or completely feminize the external genitalia, despite increasingly higher doses. Since there is no evidence of multiple 5 alpha-reductase isoenzymes to date in the rat, these results suggest that testosterone (T) can compensate for DHT to some degree at the level of the androgen receptor. Wolffian differentiation, however, was not affected by inhibition of DHT, demonstrating its T dependency, but seminal vesicle growth was impaired. Thus, inhibition of 5 alpha-reductase activity limits seminal growth potential in adulthood. Studies with the antiandrogen flutamide show that at doses significantly above that required to completely block prostate differentiation and cause genital feminization, Wolffian ductal differentiation is significantly impaired. Thus, higher doses of flutamide are needed to block the paracrine effect of T on the Wolffian ducts.


This article has been cited by other articles:


Home page
Toxicol SciHome page
R. W. Tyl, C. B. Myers, M. C. Marr, C. S. Sloan, N. P. Castillo, M. M. Veselica, J. C. Seely, S. S. Dimond, J. P. Van Miller, R. S. Shiotsuka, et al.
Two-Generation Reproductive Toxicity Evaluation of Dietary 17{beta}-Estradiol (E2; CAS No. 50-28-2) in CD-1 (Swiss) Mice
Toxicol. Sci., April 1, 2008; 102(2): 392 - 412.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Tomaszewski, A. Joseph, D. Archambeault, and H. H.-C. Yao
Essential roles of inhibin beta A in mouse epididymal coiling
PNAS, July 3, 2007; 104(27): 11322 - 11327.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Welsh, P. T. K. Saunders, and R. M. Sharpe
The Critical Time Window for Androgen-Dependent Development of the Wolffian Duct in the Rat
Endocrinology, July 1, 2007; 148(7): 3185 - 3195.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. M. Scott, G. R. Hutchison, I. K. Mahood, N. Hallmark, M. Welsh, K. De Gendt, G. Verhoeven, P. O'Shaughnessy, and R. M. Sharpe
Role of Androgens in Fetal Testis Development and Dysgenesis
Endocrinology, May 1, 2007; 148(5): 2027 - 2036.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. T. Sanderson
The Steroid Hormone Biosynthesis Pathway as a Target for Endocrine-Disrupting Chemicals
Toxicol. Sci., November 1, 2006; 94(1): 3 - 21.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Welsh, P. T. K. Saunders, N. I. Marchetti, and R. M. Sharpe
Androgen-Dependent Mechanisms of Wolffian Duct Development and Their Perturbation by Flutamide
Endocrinology, October 1, 2006; 147(10): 4820 - 4830.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Maire, A. Florin, K. Kaszas, D. Regnier, P. Contard, E. Tabone, C. Mauduit, R. Bars, and M. Benahmed
Alteration of Transforming Growth Factor-{beta} Signaling System Expression in Adult Rat Germ Cells with a Chronic Apoptotic Cell Death Process after Fetal Androgen Disruption
Endocrinology, December 1, 2005; 146(12): 5135 - 5143.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
P. M. D. Foster and M. W. Harris
Changes in Androgen-Mediated Reproductive Development in Male Rat Offspring Following Exposure to a Single Oral Dose of Flutamide at Different Gestational Ages
Toxicol. Sci., June 1, 2005; 85(2): 1024 - 1032.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
N. Atanassova, C. McKinnell, J. Fisher, and R. M Sharpe
Neonatal treatment of rats with diethylstilboestrol (DES) induces stromal-epithelial abnormalities of the vas deferens and cauda epididymis in adulthood following delayed basal cell development
Reproduction, May 1, 2005; 129(5): 589 - 601.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Florin, M. Maire, A. Bozec, A. Hellani, S. Chater, R. Bars, F. Chuzel, and M. Benahmed
Androgens and Postmeiotic Germ Cells Regulate Claudin-11 Expression in Rat Sertoli Cells
Endocrinology, March 1, 2005; 146(3): 1532 - 1540.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
N. N Atanassova, M. Walker, C. McKinnell, J. S Fisher, and R. M Sharpe
Evidence that androgens and oestrogens, as well as follicle-stimulating hormone, can alter Sertoli cell number in the neonatal rat
J. Endocrinol., January 1, 2005; 184(1): 107 - 117.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A.K. Hotchkiss, L.G. Parks-Saldutti, J.S. Ostby, C. Lambright, J. Furr, J.G. Vandenbergh, and L.E. Gray Jr
A Mixture of the "Antiandrogens" Linuron and Butyl Benzyl Phthalate Alters Sexual Differentiation of the Male Rat in a Cumulative Fashion
Biol Reprod, December 1, 2004; 71(6): 1852 - 1861.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A Bozec, F Chuzel, S Chater, C Paulin, R Bars, M Benahmed, and C Mauduit
The mitochondrial-dependent pathway is chronically affected in testicular germ cell death in adult rats exposed in utero to anti-androgens
J. Endocrinol., October 1, 2004; 183(1): 79 - 90.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. W. Leihy, G. Shaw, J. D. Wilson, and M. B. Renfree
Penile Development Is Initiated in the Tammar Wallaby Pouch Young during the Period when 5{alpha}-Androstane-3{alpha},17{beta}-Diol Is Secreted by the Testes
Endocrinology, July 1, 2004; 145(7): 3346 - 3352.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. J. Bowman, N. J. Barlow, K. J. Turner, D. G. Wallace, and P. M. D. Foster
Effects of in Utero Exposure to Finasteride on Androgen-Dependent Reproductive Development in the Male Rat
Toxicol. Sci., August 1, 2003; 74(2): 393 - 406.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. S. Fisher, S. Macpherson, N. Marchetti, and R. M. Sharpe
Human 'testicular dysgenesis syndrome': a possible model using in-utero exposure of the rat to dibutyl phthalate
Hum. Reprod., July 1, 2003; 18(7): 1383 - 1394.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Omezzine, S. Chater, C. Mauduit, A. Florin, E. Tabone, F. Chuzel, R. Bars, and M. Benahmed
Long-Term Apoptotic Cell Death Process with Increased Expression and Activation of Caspase-3 and -6 in Adult Rat Germ Cells Exposed in Utero to Flutamide
Endocrinology, February 1, 2003; 144(2): 648 - 661.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Rivas, J. S. Fisher, C. McKinnell, N. Atanassova, and R. M. Sharpe
Induction of Reproductive Tract Developmental Abnormalities in the Male Rat by Lowering Androgen Production or Action in Combination with a Low Dose of Diethylstilbestrol: Evidence for Importance of the Androgen-Estrogen Balance
Endocrinology, December 1, 2002; 143(12): 4797 - 4808.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
M. P. Longnecker, M. A. Klebanoff, J. W. Brock, H. Zhou, K. A. Gray, L. L. Needham, and A. J. Wilcox
Maternal Serum Level of 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene and Risk of Cryptorchidism, Hypospadias, and Polythelia among Male Offspring
Am. J. Epidemiol., February 15, 2002; 155(4): 313 - 322.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
P. M.D. Foster and B. S. Mcintyre
Endocrine Active Agents: Implications of Adverse and Non-Adverse Changes
Toxicol Pathol, January 1, 2002; 30(1): 59 - 65.
[Abstract] [PDF]


Home page
Toxicol SciHome page
C. J. Wolf, A. Hotchkiss, J. S. Ostby, G. A. LeBlanc, and L. E. Gray Jr.
Effects of Prenatal Testosterone Propionate on the Sexual Development of Male and Female Rats: A Dose-Response Study
Toxicol. Sci., January 1, 2002; 65(1): 71 - 86.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
B. S. McIntyre, N. J. Barlow, and P. M. D. Foster
Androgen-Mediated Development in Male Rat Offspring Exposed to Flutamide in Utero: Permanence and Correlation of Early Postnatal Changes in Anogenital Distance and Nipple Retention with Malformations in Androgen-Dependent Tissues
Toxicol. Sci., August 1, 2001; 62(2): 236 - 249.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. Ohsako, Y. Miyabara, N. Nishimura, S. Kurosawa, M. Sakaue, R. Ishimura, M. Sato, K. Takeda, Y. Aoki, H. Sone, et al.
Maternal Exposure to a Low Dose of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Suppressed the Development of Reproductive Organs of Male Rats: Dose-Dependent Increase of mRNA Levels of 5{{alpha}}-Reductase Type 2 in Contrast to Decrease of Androgen Receptor in the Pubertal Ventral Prostate
Toxicol. Sci., March 1, 2001; 60(1): 132 - 143.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
L. E. Gray Jr., J. Ostby, J. Furr, M. Price, D. N. R. Veeramachaneni, and L. Parks
Perinatal Exposure to the Phthalates DEHP, BBP, and DINP, but Not DEP, DMP, or DOTP, Alters Sexual Differentiation of the Male Rat
Toxicol. Sci., December 1, 2000; 58(2): 350 - 365.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. Lambright, J. Ostby, K. Bobseine, V. Wilson, A. K. Hotchkiss, P. C. Mann, and L. E. Gray Jr.
Cellular and Molecular Mechanisms of Action of Linuron: An Antiandrogenic Herbicide that Produces Reproductive Malformations in Male Rats
Toxicol. Sci., August 1, 2000; 56(2): 389 - 399.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. J. Wolf, G. A. LeBlanc, J. S. Ostby, and L. E. Gray Jr.
Characterization of the Period of Sensitivity of Fetal Male Sexual Development to Vinclozolin
Toxicol. Sci., May 1, 2000; 55(1): 152 - 161.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. F. Reckelhoff, H. Zhang, K. Srivastava, and J. P. Granger
Gender Differences in Hypertension in Spontaneously Hypertensive Rats : Role of Androgens and Androgen Receptor
Hypertension, October 1, 1999; 34(4): 920 - 923.
[Abstract] [Full Text] [PDF]


Home page
Toxicol Ind HealthHome page
C. Wolf, C. Lambright, P. Mann, M. Price, R. L. Cooper, J. Ostby, and L. E. Gray Jr.
Administration of potentially antiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, p,p'-DDE, and ketoconazole) and toxic substances (dibutyl- and diethylhexyl phthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation produces diverse profiles of reproductive malformations in the male rat
Toxicology and Industrial Health, February 1, 1999; 15(1-2): 94 - 118.
[Abstract] [PDF]


Home page
EndocrinologyHome page
B. A. Foster and G. R. Cunha
Efficacy of Various Natural and Synthetic Androgens to Induce Ductal Branching Morphogenesis in the Developing Anterior Rat Prostate
Endocrinology, January 1, 1999; 140(1): 318 - 328.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
T.-M. Lin and C. Chang
Cloning and characterization of TDD5, an androgen target gene that is differentially repressed by testosterone and dihydrotestosterone
PNAS, May 13, 1997; 94(10): 4988 - 4993.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. D. Katz, I. Kligman, L.-Q. Cai, Y.-S. Zhu, C. M. Fratianni, I. Zervoudakis, Z. Rosenwaks, and J. Imperato-McGinley
Paternity by Intrauterine Insemination with Sperm from a Man with 5{alpha}-Reductase-2 Deficiency
N. Engl. J. Med., April 3, 1997; 336(14): 994 - 998.
[Full Text] [PDF]


Home page
NEJMHome page
R. S. Rittmaster
Finasteride
N. Engl. J. Med., January 13, 1994; 330(2): 120 - 125.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society